Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 4, 2006, Pages 1034-1041

  Levine, Richard J ^a   Qian, Cong ^b   Maynard, Sharon E ^c   Yu, Kai F ^a   Epstein, Franklin H ^d   Karumanchi, S Ananth ^d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Allied Technology Group   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Blood pressure; Cardiovascular disease; Placental growth factor; Preeclampsia; sFlt1; Soluble fms like tyrosine kinase 1

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HUMAN; LABOR; NULLIPARA; OUTCOME ASSESSMENT; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; SECOND TRIMESTER PREGNANCY; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HUMANS; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 33645895289     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.10.192     Document Type: Article

References (36)

1. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
2. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
3. Yang J.C., Haworth L., Sherry R.M., Hwu P., Schwartzenruber D.J., Topalian S.L., et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349 (2003) 427-434
4. Roberts J.M., Taylor R.N., Musci T.J., Rogers G.M., Hubel C.A., and McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 (1989) 1200-1204
5. Duckitt K., and Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330 (2005) 565-571
6. Sibai B.M., Gordon T., Thom E., Caritis S.N., Klebanoff M., McNellis D., et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. Am J Obstet Gynecol 172 (1995) 642-648
7. Sibai B.M., Ewell M., Levine R.J., Klebanoff M.A., Esterlitz J., Catalano P.M., et al. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 177 (1997) 1003-1010
8. Caritis S., Sibai B., Hauth J., Lindheimer M., VanDorsten P., Klebanoff M., et al. Predictors of pre-eclampsia in women at high risk. Am J Obstet Gynecol 179 (1998) 946-951
9. Chaiworapongsa T., Romero R., Espinoza J., Bujold E., Kim Y.M., Goncalves L.F., et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstet Gynecol 190 (2004) 1541-1550
10. Chaiworapongsa T., Romero R., Kim Y.M., Kim G.J., Kim M.R., Espinoza J., et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 17 (2005) 3-18
11. Levine R.J., Hauth J.C., Curet L.B., Sibai B.M., Catalano P.M., Morris C.D., et al. Trial of calcium to prevent preeclampsia. N Engl J Med 337 (1997) 69-76
12. Levine R.J., Esterlitz J.R., Raymond E.G., DerSimonian R., Hauth J.C., Curet L.B., et al. Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methods. Control Clin Trials 17 (1996) 442-469
13. Zhang J., and Bowes Jr. W.A. Birth-weight-for-gestational-age patterns by race, sex, and parity in the United States population. Obstet Gynecol 86 (1995) 200-208
14. Ness R.B., and Roberts J.M. Heterogeneous causes constituting the single syndrome of preeclampsia: an hypothesis and its implications. Am J Obstet Gynecol 175 (1996) 1365-1370
15. Yogev Y., Xenakis E.M.J., and Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol 191 (2004) 1655-1660
16. Akbari C.M., Saouaf R., Barnhill D.F., Newman P.A., LoGerfo F.W., and Veves A. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg 28 (1998) 687-694
17. Williams S.B., Goldfine A.B., Timimi F.K., Ting H.H., Roddy M.A., Simonson D.C., et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97 (1998) 1695-1701
18. Marfella R., Nappo F., De Angelis L., Paolisso G., Tagliamonte M.R., and Giugliano D. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care 23 (2000) 658-663
19. Thadhani R., Ecker J.L., Mutter W.P., Wolf M., Smirnakis K.V., Sukhatme V.P., et al. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension 43 (2004) 988-992
20. Vincent D., Ilany J., Kondo T., Naruse K., Fisher S.J., Kisanuki Y.Y., et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 111 (2003) 1373-1380
21. Page E.W., and Christianson R. The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am J Obstet Gynecol 125 (1976) 740-746
22. Moutquin J.M., Rainville C., Giroux L., Raynauld P., Amyot G., Bilodeau R., et al. A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol 151 (1985) 191-196
23. Villar M.A., and Sibai B.M. Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic or diastolic blood pressure during third trimester. Am J Obstet Gynecol 160 (1989) 419-423
24. Reiss R.E., O'Shaughnessy R.W., Quilligan T.J., and Zuspan F.P. Retrospective comparison of blood pressure course during preeclamptic and matched control pregnancies. Am J Obstet Gynecol 156 (1987) 894-898
25. Reiss R.J., Tizzano T.P., and O'Shaughnessy R.W. The blood pressure course in primiparous pregnancy. J Reprod Med 32 (1987) 523-526
26. Odegard R.A., Vatten L.J., Nilsen S.T., Salvesen K.A., and Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. BJOG 107 (2000) 1410-1416
27. Stamilio D.M., Sehdev H.M., Morgan M.A., Propert K., and Macones G.A. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?. Am J Obstet Gynecol 182 (2000) 589-594
28. Xiong X., Demianczuk N.N., Buekens P., and Saunders L.D. Association of preeclampsia with high birthweight for age. Am J Obstet Gynecol 183 (2000) 148-155
29. Xiong X., Demianczuk N.N., Saunders L.D., Wang F.L., and Fraser W.D. Impact of preeclampsia and gestational hypertension on birthweight by gestational age. Am J Epidemiol 155 (2002) 203-209
30. Vatten L.J., and Skjaerven R. Is pre-eclampsia more than one disease. BJOG 111 (2004) 298-302
31. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16 (1998) 5-15
32. Innes K.E., Weitzel L., and Laudenslager M. Altered metabolic profiles among older mothers with a history of preeclampsia. Gynecol Obstet Invest 59 (2005) 192-201
33. Smith G.C., Pell J.P., and Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet 357 (2001) 2002-2006
34. Irgens H.U., Reisaeter L., Irgens L.M., and Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323 (2001) 1213-1217
35. Funai E.F., Friedlander Y., Paltiel O., Tiram E., Xue X., Deutsch L., et al. Long-term mortality after preeclampsia. Epidemiology 16 (2005) 206-215
36. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 (1998) 3527-3561